Akèy › BPCO › New York › Queens
Etid klinik pou BPCO nan Queens, NY
4 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- New York Hospital Queens- Site Number : 8400058, Flushing · 6 mi lwen
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Ap rekriteFaz 3
- Research Site, Massapequa · 19 mi lwen
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 2/3
- New York Presbyterian Queens, Flushing · 6 mi lwen
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 3
- Research Site, Massapequa · 19 mi lwen
Etid BPCO nan lòt vil
- Philadelphia, PA23 etid
- Miami, FL18 etid
- Birmingham, AL17 etid
- Boston, MA17 etid
- Orlando, FL15 etid
- Houston, TX15 etid
- Baltimore, MD14 etid
- Chicago, IL14 etid
- Pittsburgh, PA12 etid
- Dallas, TX12 etid
- New York City, NY11 etid
- Ann Arbor, MI10 etid
Lòt etid nan Queens
- Kansè nan tete63 etid
- Kansè Poumon ki pa ti selil49 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Kansè ovè28 etid
- Kansè pwostat27 etid
- Kansè (tout kalite)25 etid
- Kansè Endomèt25 etid
- Kansè poumon22 etid
- Leksemi mieloïd egi21 etid
- Karsinòm selil skuamèz tèt ak kou20 etid
- Myelom Miltip20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.